October 24, 2020

The Niche

Knoepfler lab stem cell blog

iPS cell RPE

2 min read

In a rare sign of stem cell international regulatory unity, the Japanese Health Ministry (厚生労働省) and the US FDA have agreed to develop a joint, unified regulatory framework for clinical studies of human iPS cells for use in treating retinal diseases. Presumably the rules would also guide clinical use of iPS cells to treat other diseases. The two regulatory bodies aim to have the joint rules in place by 2015. To me this seems like a positive development, but it may come a bit …Read More

6 min read

When are iPS cell-based therapies ready to be tested in actual people? It’s the million or perhaps even billion dollar question of today in the stem cell field. I realize that perhaps it is also a dangerous question, politically-speaking, for me to ask in a public forum, but patient lives as well as potentially the progress of the entire iPS cell field are at stake. So someone needs to start an open discussion about this topic. People are certainly talking about it behind the …Read More